Selection of prostate cancer therapy strategy under early androgen suppression treatment

DOI10.1016/J.CNSNS.2024.107914MaRDI QIDQ6199715zbMATH OpenFDO

Authors Miaoran Yao, Yongxin Zhang, Wendi Wang

Publication date 21 March 2024

Published in Communications in Nonlinear Science and Numerical Simulation (Search for Journal in Brave)

zbMATH Keywords

hybrid modelperiodic solutiontreatmentpharmacodynamicsoptimal regimen

Mathematics Subject Classification ID

Medical applications (general) (92C50) Periodic solutions to ordinary differential equations (34C25)

Recommendations

• Comparison between mathematical models of intermittent androgen suppression for prostate cancer
• Modeling prostate cancer response to continuous versus intermittent androgen ablation therapy
• Mathematical modeling of continuous and intermittent androgen suppression for the treatment of advanced prostate cancer
• A new protocol for intermittent androgen suppression therapy of prostate cancer with unstable saddle-point dynamics
• Optimization therapy by coupling intermittent androgen suppression with impulsive chemotherapy for a prostate cancer model

Cites work

• A mathematical model of intermittent androgen suppression for prostate cancer
• Analysis of mathematical model of prostate cancer with androgen deprivation therapy
• Development of a mathematical model that predicts the outcome of hormone therapy for prostate cancer
• Dynamical systems in population biology
• Dynamics and implications of models for intermittent androgen suppression therapy
• Global dynamics of a model of joint hormone treatment with dendritic cell vaccine for prostate cancer
• Modeling prostate cancer response to continuous versus intermittent androgen ablation therapy

Cited in

(1)

• A joint-threshold Filippov model describing the effect of intermittent androgen-deprivation therapy in controlling prostate cancer

This page was built for publication: Selection of prostate cancer therapy strategy under early androgen suppression treatment

Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q6199715)